Laurent DECORYJan 4, 20211 minCOVID-19 to reshape R&D investments toward infectious diseasesInfectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...
Laurent DECORYDec 16, 20201 minCovid-19 vaccine approval to massively accelerate mRNA innovationWith COVID-19 vaccine authorization, BioNTech SE and Pfizer open the door for massive acceleration of mRNA innovation, in...
Laurent DECORYDec 16, 20201 minModerna Covid-19 vaccine: 94% efficacy with easier storageFollowing Pfizer-BioNTech 90% efficacy announcement, Moderna data show 94% efficacy against Covid-19, while allowing easier storage: long...
